Navigation Links
Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
Date:10/2/2007

le diseases including diabetes.

In the last five years, JDRF has funded more than $40 million in research utilizing adult and embryonic stem cells in the U.S. and around the world. JDRF committed funds early on for the derivation of new stem cell lines, and last year spent about $3 million on research utilizing embryonic stem cells and about $1.6 million on adult stem cells. In total, JDRF funded some $137 million in science last year aimed at developing cures and therapeutics for type 1 diabetes and its complications.

Mr. Donald noted that JDRF has recently developed a number of initiatives to support new programs in research, including science utilizing stem cells, in order to attract new scientific talent to the field and stimulate creative thinking about diabetes research. He specifically pointed to JDRF's recently initiated Industry Discovery and Development Partnership program, a "trend- setting program for a non-profit organization." Through the IDDP program, JDRF makes matching grants -- or sometimes invests side-by-side with venture capitalists -- in high-promise projects at for-profit businesses, typically small start-ups or spin-offs. The program now includes 14 partnerships with companies, representing some $20 million, which are involved in pre-clinical research, as well as Phase 1 and Phase 2 human clinical trials.

Through the IDDP program, JDRF partnered with a Pittsburgh-based company, Stemnion, to investigate the ability of stem cells found on the inner membrane of the amnion to differentiate into insulin-secreting cells. JDRF also funded stem cell research at San Diego-based Novocell that resulted in the generation of GMP quality embryonic stem cell lines.

JDRF was founded in 1970 by the parents of children with type 1 diabetes - - a disease that strikes children, adolescents, and adults suddenly, makes them insulin-dependent for life, and carries the constant threat of devastating complications. Since inception, JDRF has pr
'/>"/>

SOURCE Juvenile Diabetes Research Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Advantages of Roche Applied Science amplification products
2. Tools for Proteomic Science II
3. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
4. Food science: increasing crop yields
5. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
6. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
7. NanoRite Innovation Center opens with small science, big promise
8. Midwest life science stocks kept sizzling in Q2
9. Perscitus Biosciences secures $250K Commerce loan
10. Wisconsin biosciences rise to the challenge
11. Wisconsin professors elected to National Academy of Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 The third edition of ... , published by the Infusion Nurses Society ... anthracycline extravasation.(1) Anthracyclines are a group of ... that have been used in the treatment of ... ,, According to the INS publication: ...
(Date:12/14/2009)... Dec. 14 Lionbridge (Nasdaq: ... signed a new, three-year master services agreement ... products and services that serve patients in ... will become the sole provider for translation ... regulatory, marketing, training, human resources, legal, and ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB ... Industrialized Countries , , - A third ... impacts their enjoyment of the festive ... find shopping for gifts, preparing ... difficult to do, - ...
Breaking Biology Technology:Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4
... flexibility for placement in small, medium and ... ... Boston Scientific,Corporation (NYSE: BSX ) today announced CE Mark approval ... therapy,defibrillators and cardiac resynchronization therapy pacemakers, both of,which treat heart failure. ...
... Pennysylvania, March 3, Shire plc (LSE: SHP)(NASDAQ: ... Renovo Group plc, (LSE:,RNVO) ("Renovo") has today announced ... JUVISTA(R) (human recombinant TGFbeta3) in scar revision surgery,(RN1001-319-1009) ... release can be found on http://www.renovo.com ., ...
... France, March 3 NicOx S.A.,(Euronext Paris: COX) ... studies in the United States, which will assess ... ibuprofen and naproxen,using the Ambulatory Blood Pressure Monitoring ... in duration, will together recruit a,total of around ...
Other Biology Technology:Boston Scientific Announces European Approval of New Heart Failure Lead 2Boston Scientific Announces European Approval of New Heart Failure Lead 3Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3) 2Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3) 3NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 2NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 4NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 5
(Date:12/14/2009)... 14, 2009) -- Researchers at Rice University and Baylor ... that can be tracked in real time with MRI ... with a fluorescent dye and kills them with heat. ... from a growing field called "theranostics" that develops technologies ... a single procedure. , The research is available online ...
(Date:12/14/2009)... (BMES) have founded a new journal Cardiovascular Engineering ... is a forum for research on all aspects ... issue of the new quarterly journal will appear in ... Springer, Annals of Biomedical Engineering and ... and Technology will present a wide spectrum of ...
(Date:12/14/2009)... feature of humans. That,s until examples of tool use came ... of other mammals. Now, a report in the December 14th ... adds an octopus to the growing list of tool users. ... that the researchers call stilt walking. In it, the soft-bodied ... its eight arms rigid, and raises the whole assembly to ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 1Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 4Blood Test Shows Statistically Significant Association With Alzheimers Disease 28AD 29 May Predict Conversion of Mild Cognitive Impairment to AD 51872 1Blood Test Shows Statistically Significant Association With Alzheimers Disease 28AD 29 May Predict Conversion of Mild Cognitive Impairment to AD 51872 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 1AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 3
... German . , Because of its toxicity and ... can no longer be used or produced in many countries. ... hydrocarbons, such as chloroform (trichloromethane, CHCl3), also produce CCl4 as ... of this unwanted substance? A team headed by Bert M. ...
... today called for Europe to invest more funds into the ... crucial role in the function of human cells and which ... diabetes to Alzheimer,s. , Common lipids such as cholesterol are ... of cells and tissues, but human cells contain thousands of ...
... June 16, 2008 -- VaxInnate Corporation announced today that it ... pandemic influenza vaccines during BIO 2008 here this week. ... three BIO 2008 panel discussions: , On Tuesday, ... Preparing for the Next Pandemic," , 8:15-9:45 am in Room ...
Other Biology News:Fair trade 2Europe-wide investment in lipid research will help tackle disease, says new report 2VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week 2
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... This CLS number ... number, created to easily ... If showing no availability ... the old Sigma-Aldrich number ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... pressure gradient system uses three Adept CE ... a flow rate in one microlitre increaments. ... added flexibility. System control and data processing ... interface unit, CE 4900., Column heater/chillers can be ...
Biology Products: